Views & Analysis Roundup: Pharma news from HLTH 2022 Although originally focused more on providers and health tech, the US conference HLTH has been steadily widening its scope and now hosts a wide variety of healthcare stakeholders.
Patients On patient-centric treatment decisions and the value of quan... Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face